CMAC 2001; 3(2) | CMAC

CMAC 2001; 3(2)

Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):98-104
PDF

Translated and reprinted with permission from «ASM News» 2000; 66:732-7.

Concerted efforts, perhaps involving meta-analysis …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):104-111
PDF

The mechanisms of resistance to aminoglycoside antibiotics in Gram-negative nosocomial pathogens isolated in four Russian hospitals …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):111-125
PDF

Translated and reprinted with permission from «Emerging Infectious Diseases» 2000; 6:552-6.

Resistance of Streptococcus …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):126-132
PDF

Translated and reprinted with permission from «International Journal of Antimicrobial Agents» 2001;17:9-19.

Antimicrobial use is the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):133-147
PDF

Case histories of outpatients with acute exacerbation of chronic bronchitis (AECB) were analyzed. Diagnoses were classified according …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):148-155
PDF

Two rapid, phenotypic methods were developed for the detection of diphtheria toxin amongst clinical isolates of corynebacteria, an …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):156-162
PDF

There is increasing recognition of a widening array of enteric patogens associated with illnesses of the gastrointestinal tract. Along …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):163-182
PDF

Production of extended-spectrum β-lactamases (ESBL) is the one of most widespread and clinically significant mechanism of resistance to …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):183-189
PDF

Criteria for the evaluation of vaginal biocenosis developed in the Research Center of Obstetrics, Gynecology and Perinatology of the …
Clinical Microbiology and Antimicrobial Chemotherapy. 2001; 3(2):190-194
PDF